179 related articles for article (PubMed ID: 12644586)
1. Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway.
Kwok JC; Richardson DR
Mol Pharmacol; 2003 Apr; 63(4):849-61. PubMed ID: 12644586
[TBL] [Abstract][Full Text] [Related]
2. Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents.
Kwok JC; Richardson DR
Mol Pharmacol; 2004 Jan; 65(1):181-95. PubMed ID: 14722250
[TBL] [Abstract][Full Text] [Related]
3. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
Minotti G; Cavaliere AF; Mordente A; Rossi M; Schiavello R; Zamparelli R; Possati G
J Clin Invest; 1995 Apr; 95(4):1595-605. PubMed ID: 7706466
[TBL] [Abstract][Full Text] [Related]
4. Unexpected anthracycline-mediated alterations in iron-regulatory protein-RNA-binding activity: the iron and copper complexes of anthracyclines decrease RNA-binding activity.
Kwok JC; Richardson DR
Mol Pharmacol; 2002 Oct; 62(4):888-900. PubMed ID: 12237336
[TBL] [Abstract][Full Text] [Related]
5. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritin.
Corna G; Santambrogio P; Minotti G; Cairo G
J Biol Chem; 2004 Apr; 279(14):13738-45. PubMed ID: 14739295
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of nitrogen monoxide (NO)-mediated iron mobilization from cells. NO intercepts iron before incorporation into ferritin and indirectly mobilizes iron from ferritin in a glutathione-dependent manner.
Watts RN; Richardson DR
Eur J Biochem; 2002 Jul; 269(14):3383-92. PubMed ID: 12135476
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: implications for cardiotoxicity of anticancer anthracyclines.
Menna P; Salvatorelli E; Giampietro R; Liberi G; Teodori G; Calafiore AM; Minotti G
Chem Res Toxicol; 2002 Sep; 15(9):1179-89. PubMed ID: 12230412
[TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacology of the interaction of anthracyclines with iron.
Xu X; Persson HL; Richardson DR
Mol Pharmacol; 2005 Aug; 68(2):261-71. PubMed ID: 15883202
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.
Minotti G; Ronchi R; Salvatorelli E; Menna P; Cairo G
Cancer Res; 2001 Dec; 61(23):8422-8. PubMed ID: 11731422
[TBL] [Abstract][Full Text] [Related]
11. Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism.
Lane DJ; Chikhani S; Richardson V; Richardson DR
Biochim Biophys Acta; 2013 Jun; 1833(6):1527-41. PubMed ID: 23481043
[TBL] [Abstract][Full Text] [Related]
12. Release of iron from ferritin by cardiotoxic anthracycline antibiotics.
Thomas CE; Aust SD
Arch Biochem Biophys; 1986 Aug; 248(2):684-9. PubMed ID: 3017216
[TBL] [Abstract][Full Text] [Related]
13. Ferritin stimulation of hydroxyl radical production by rat liver nuclei.
Kukiełka E; Cederbaum AI
Arch Biochem Biophys; 1994 Jan; 308(1):70-7. PubMed ID: 8311476
[TBL] [Abstract][Full Text] [Related]
14. IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice.
Corna G; Galy B; Hentze MW; Cairo G
J Mol Med (Berl); 2006 Jul; 84(7):551-60. PubMed ID: 16770644
[TBL] [Abstract][Full Text] [Related]
15. Iron transfer form transferrin to ferritin mediated by polyphosphate compounds.
Konopka K; Mareschal JC; Crichton RR
Biochim Biophys Acta; 1981 Nov; 677(3-4):417-23. PubMed ID: 6271255
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantitation of iron in ferritin, transferrin and labile iron pool (LIP) in cardiomyocytes using
Krijt M; Jirkovska A; Kabickova T; Melenovsky V; Petrak J; Vyoral D
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2895-2901. PubMed ID: 30279145
[TBL] [Abstract][Full Text] [Related]
17. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis.
Stites SW; Plautz MW; Bailey K; O'Brien-Ladner AR; Wesselius LJ
Am J Respir Crit Care Med; 1999 Sep; 160(3):796-801. PubMed ID: 10471599
[TBL] [Abstract][Full Text] [Related]
18. Ferritin as a cytosol iron transport intermediate in human reticulocytes.
Speyer BE; Fielding J
Br J Haematol; 1979 Jun; 42(2):255-67. PubMed ID: 465371
[TBL] [Abstract][Full Text] [Related]
19. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
[TBL] [Abstract][Full Text] [Related]
20. Effect of a prolonged superoxide flux on transferrin and ferritin.
Paul T
Arch Biochem Biophys; 2000 Oct; 382(2):253-61. PubMed ID: 11068877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
